Rhythm Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RYTM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

549,020

Value ($000)

58,767

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	58,767	0.0%	549,020	12/31/2025
2025 Q3	11/14/2025	44,180	0.0%	437,472	9/30/2025
2025 Q2	8/14/2025	14,384	0.0%	227,627	6/30/2025
2025 Q1	5/19/2025	6,663	0.0%	125,782	3/31/2025
2024 Q4	2/14/2025	12,234	0.0%	218,544	12/31/2024
2024 Q3	11/14/2024	11,807	0.0%	225,373	9/30/2024
2024 Q2	8/14/2024	9,708	0.0%	236,431	6/30/2024
2024 Q1	5/15/2024	8,968	0.0%	206,980	3/31/2024
2023 Q4	2/14/2024	9,651	0.0%	209,938	12/31/2023
2023 Q3	11/13/2023	7,732	0.0%	337,264	9/30/2023
2023 Q2	8/11/2023	3,676	0.0%	206,035	6/30/2023
2023 Q1	5/15/2023	3,676	0.0%	206,035	3/31/2023
2022 Q4	2/14/2023	1,229	0.0%	42,197	12/31/2022
2022 Q3	11/14/2022	733	0.0%	29,937	9/30/2022
2022 Q2	8/12/2022	228	0.0%	54,823	6/30/2022
2022 Q1	5/16/2022	339	0.0%	29,431	3/31/2022
2021 Q4	2/14/2022	294	0.0%	29,431	12/31/2021
2021 Q3	11/15/2021	329	0.0%	25,215	9/30/2021
2021 Q2	8/16/2021	494	0.0%	25,215	6/30/2021
2021 Q1	5/14/2021	223	0.0%	10,496	3/31/2021
2020 Q4	3/1/2021	866	0.0%	29,126	12/31/2020
2020 Q3	11/13/2020	693	0.0%	31,964	9/30/2020
2020 Q2	8/14/2020	425	0.0%	19,063	6/30/2020